A device for real-time monitoring and predicting outcomes in cardiovascular surgeries and sepsis.
A real-time monitoring and predictive device for cardiovascular surgeries and sepsis
This study is working on a new device that can quickly check for sepsis during heart surgeries by analyzing urine, helping doctors catch this serious condition early and improve patient care.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Arizona State University-Tempe Campus NIH-funded |
| Lab location | 1 site (Tempe, United States) |
| Project ID | NIH-11040890 on NIH RePORTER |
What this research studies
This research focuses on developing a real-time monitoring device that can predict and diagnose sepsis, a severe condition that can arise during cardiovascular surgeries. By utilizing non-invasive urine analysis and biomarkers, the device aims to provide rapid diagnosis and intervention, potentially saving lives and preserving organ function. The approach includes algorithm development for accurate detection of sepsis, which is often challenging due to nonspecific symptoms. The research team has conducted preliminary animal studies to assess the effectiveness of urine biomarkers in diagnosing sepsis.
Who could benefit from this research
Good fit: Ideal candidates for this research include patients undergoing cardiovascular surgeries or those at risk of developing sepsis.
Not a fit: Patients with non-cardiovascular conditions or those not at risk for sepsis may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to earlier and more accurate diagnosis of sepsis, significantly improving patient outcomes during critical medical situations.
How similar studies have performed: Other research has shown promise in using non-invasive methods for diagnosing sepsis, indicating that this approach could be a meaningful advancement in the field.
Where this research is happening
Tempe, United States
- Arizona State University-Tempe Campus — Tempe, United States (Active)
Researchers
- Principal investigator: Forzani, Erica Silvia — Arizona State University-Tempe Campus
- Study coordinator: Forzani, Erica Silvia
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.